Kennedy Capital Management’s Aprea Therapeutics APRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,740	Closed	-$623K	–	602
2022 Q1	$623K	Sell	16,740 -97	-0.6%	-$3.98K	0.01%	541
2021 Q4	$966K	Sell	16,837 -287	-2%	-$25.4K	0.02%	520
2021 Q3	$1.75M	Sell	17,124 -572	-3%	-$52K	0.04%	480
2021 Q2	$1.73M	Buy	17,696 +15,075	+575%	+$1.39M	0.04%	490
2021 Q1	$267K	Buy	+2,621	New	+$306K	0.01%	639
2020 Q4	–	Sell	-9,368	Closed	-$4.51M	–	664
2020 Q3	$4.51M	Buy	9,368 +2,797	+43%	+$1.57M	0.13%	301
2020 Q2	$5.1M	Buy	6,571 +209	+3%	+$137K	0.15%	268
2020 Q1	$4.42M	Buy	6,362 +1,713	+37%	+$1.26M	0.16%	222
2019 Q4	$4.27M	Buy	+4,649	New	+$2.56M	0.1%	379